Spotlight
Video

Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC [720p]

cancergrace has 1140 videos Subscribe Here

Loading........
Description: Dr. Ross Camidge, University of Colorado, describes the second generation ALK-inhibitors which provide good options for ALK-positive NSCLC patients who have developed acquired resistance to crizotinib.
Shared By : cancergrace
Posted on : 05/16/18
Added : 1 year ago